Literature DB >> 31171479

Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance program.

Carmela Caballero1, Susen Burock2, Lucia Carrion-Alvarez3, Henrik Nilsson4, Theo Ruers5, Perrine Senellart6, Michel Rivoire6, Stefan Stattner7, Florian Primavesi7, Roberto Troisi8, Thomas Gruenberger9, Jan Heil10, Andreas A Schnitzbauer10, Nuh N Rahbari11, Rutger-Jan Swijnenburg12, Hassan Malik13, Mladjan Protic14, Kozo Kataoka15, Murielle Mauer16, Michel Ducreux17, Graeme Poston13, Serge Evrard18.   

Abstract

The challenges of conducting surgical oncology trials have resulted to low quantity and poor quality research [1,2]. Considering the definitive role of surgery to offer cure, immediate response to improve surgical research is needed [3]. The European Organization for Research and Treatment of Cancer (EORTC) and the European Society of Surgical Oncology (ESSO) share the vision to achieve excellent surgical research and care for cancer patients. Building on their complimentary expertise, they embarked on a pilot project to map out challenges and initiate a sustainable collaboration to advance cancer surgery research in Europe. This pilot project is EORTC-ESSO 1409 GITCG/ ESSO-01: A Prospective Colorectal Liver Metastasis Database with an Integrated Quality Assurance Program (CLIMB). This article will describe the challenges, milestones and vision of both organizations in setting up this collaboration.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31171479     DOI: 10.1016/j.ejso.2019.05.028

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

1.  [Unexpectedly high mortality after surgical liver interventions in Germany].

Authors:  David Krug; Ralf Hofheinz; Eleni Gkika; Thomas Brunner; Judit Boda-Heggemann
Journal:  Strahlenther Onkol       Date:  2020-01       Impact factor: 3.621

2.  Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre.

Authors:  Katja Reuter; Carina Haupt; Anna Molto; Andrew Cope; Ronald F van Vollenhoven; Dirk Elewaut; Rik Lories; Iain B McInnes
Journal:  RMD Open       Date:  2022-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.